Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Watch the great Frontline video interview with Burlakoff here -https://youtu.be/NqXZnAczbkM
Prikaži ovu nit -
Google Health’s David Feinberg said it was a “difficult decision” to leave healthcare for tech. He had to make sure Google would allow him to treat the users of Google’s health services as if they were his own patients.pic.twitter.com/YusOh8tvOi
Prikaži ovu nit -
Bernie Sanders buying 'patients before profits' ads saying he will take on the drug companies over high prices.https://www.youtube.com/watch?v=hpauI9rdwRc&feature=emb_title&utm_source=STAT+Newsletters&utm_campaign=df83284387-dc_diagnosis_COPY_04&utm_medium=email&utm_term=0_8cab1d7961-df83284387-151148505 …
-
A whistleblower has leaked documents which he or she claims are from the Google-Ascension health data sharing partnership 'Project Nightingale' https://www.dailymotion.com/video/x7nvz43
-
Pharma companies must listen to what matters to patients. Takeda changed its clinical trial from measuring success on a 6 min walk test to a peg test for dexterity because patients said it was more important. But it had to battle with the FDA to get that change.
#FTPharmapic.twitter.com/owcT2aCUjh
-
Fascinating parallel: The pharma industry lost people’s confidence on animal testing when it stayed silent. But when it starting engaging, it changed the debate. The same could happen now with questions about how it uses patient data, argues Lord Drayson from Sensyne
#FTPharmapic.twitter.com/yaMbuYMV1f
-
Wow: doctors, the tech industry is coming for your relationship with patients. According to our
#FTpharma audience poll, tech companies are only just behind physicians in being best placed to build strong commercial relationships with patients. Pharma is way behind.pic.twitter.com/krVwhnXj5P
-
Bill Clinton: There are many of other countries that have vibrant pharmaceutical industries - like Germany. And they have price controls. Allowing the US government to negotiate prices would make a big difference.
#Time100Healthpic.twitter.com/krj1HXjoBT
-
Some negative sentiment here on the US healthcare system. Or is that an understatement?
#TIME100Healthpic.twitter.com/aYDJZsXllc
-
Apple now has a tea timer. Totally unnecessary for Brits who know this instinctively but please take note Americans. Next can they add how to use actually hot water and how much milk to put in?pic.twitter.com/lqKU9TiXN3
-
About 80 per cent of a patient advocacy orgs take funding from pharma companies. Only 5 per cent declare that money.
#FTPharmaPricingpic.twitter.com/OMm8Y8kThl
-
Kaiser Permanente SVP Tony Barrueta says there is “incredibly strong political pressure” to fastrack drug approvals - with small studies that make it hard for doctors to know if they are effective and insurers to know if its good value
#FTPharmaPricingpic.twitter.com/Yv7PcExie1
Prikaži ovu nit -
Mark Trusheim from MIT argues biosimilars should be made by the branded companies and regulated as utilities, with a set percentage of profit. At the moment, rivals tend to produce the generic alternatives to biologics.
#FTPharmaPricingpic.twitter.com/aZhNnIT9Og
-
“Everyone is for value based reimbursement- as long as they get to define what the value is” says Chip Davis of the Association for Accessible Medicines. It’ll be “tough slog” to get people to agree on what the value is.
#FTPharmaPricingpic.twitter.com/LnjRRRgRen
-
AstraZeneca is telling payers they won’t charge if a drug isn’t working as it did in trials. And yes, it has returned money, with a cancer drug that doesn’t work in 2/10 people.
#FTPharmaPricingpic.twitter.com/25BSZfbjq7
-
The American Medical Association is pushing the FDA to do more on e-cigarettes, as vaping causes a mysterious lung illness across the US.pic.twitter.com/sz3KOvv2Lg
-
Crowds including US diabetic patients outside a pharmacy in Canada cheer as
@BernieSanders says if drug companies engage in price-fixing, the US should throw them in jail.pic.twitter.com/BfceBezHPy -
It is a scary time to invest in biotech, with so much new private and public capital says Heather Preston at Pivotal Bioventure Partners. “It is a pretty heady time - great if you are trying to exit - but if you’re making investments, it is tough to find that value”.
#FTUSPharmapic.twitter.com/mIDOZutG4z
-
There’s not enough innovation in the tech sector says Amy Abernethy at the FDA. She said she joined the FDA to write enabling regulations to push the tech forward.
#FTUSPharmapic.twitter.com/LvlqtJ2Y6h
-
http://Humanity.co offers “consent as a service”. For patient data, not for avoiding
#metoo
situations. Although I guess that could be another use of blockchain... #FTUSPharmapic.twitter.com/47ySWfuHF5
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.